Nūhou
-
Komo ʻo IPHASE i ka 64th SOT Annual Meeting a me ToxExpo
Hoʻokomo ʻo IPHASE i ka 64th SOT Annual Meeting a me ToxExpoMa ke ʻano he hoa hilinaʻi ma ke kahua o nā bioreagents no ka metabolism lāʻau a me nā pharmacokinetics, haʻaheo ʻo IPHASE e komo i ka 64th AnnuHeluhelu hou aku -
He aha ka S9 i hoʻokomo ʻia?
Introduction to Induced S9Induced S9 he ate-i loaʻa i ka ʻāpana enzyme i hoʻohana mau ʻia i ka ʻona a me ka noiʻi biochemical. Hoʻomākaukau ʻia ia ma ka hoʻoulu ʻana i nā enzyme ate i nā holoholona, e like me nā ʻiole a i ʻole hamHeluhelu hou aku -
Plateable Hepatocytes vs. Suspension Hepatocytes: Nā ʻokoʻa koʻikoʻi a me nā noi i ka hoʻāʻo lāʻau.
I. IntroductionMa ka hoʻomohala ʻana i ka lāʻau a me ka noiʻi toxicology, he kuleana koʻikoʻi nā hepatocytes i ka loiloi ʻana i ka metabolism a me ka palekana o nā moho lāʻau hou. I waena o lākou, he plateable hepatocytes a me ka suspenHeluhelu hou aku -
CGT Inovative Therapy - Lentivirus-packaging CAR-T immune cell
CGT Inovative Therapy - Lentivirus-packagingCAR-T immune cell He lāʻau lapaʻau ʻo ka maʻi kanesa hou e hoʻonui ai i ka ʻōnaehana pale o ke kino e hoʻopaʻa a hoʻopau i nā pūnaeau maʻi maʻi. Ki fHeluhelu hou aku -
ʻO nā Microsomes Liver kanaka i ka hoʻomohala ʻana i ka lāʻau lapaʻau: pehea lākou e hopena ai i ka Pharmacokinetics
1. Introduction: Understanding Human Liver Microsomes I ka hoʻomohala ʻana i ka lāʻau lapaʻau hou, he mea koʻikoʻi ka wānana ʻana i ka hana ʻana o ka lāʻau i loko o ke kino o ke kanaka no ka hōʻoia ʻana i ka pono a me ka palekana. Ake kanaka mHeluhelu hou aku -
Haʻaheo ʻo IPHASE e komo i ka 2025 CBA-GP Biomedical Science Symposium
Ma ke ʻano he mea pāʻani koʻikoʻi ma ke kahua o ka hana hou biomedical, hauʻoli ʻo IPHASE e komo i ka 2025 CBA-GP Biomedical Science Symposium a loaʻa iā ia ka manawa e hui pū me nā loea, nā mea hou,Heluhelu hou aku -
Nā Hepatocytes Mua: He mea hana koʻikoʻi no ka holomua ʻana i ka noiʻi lāʻau non-clinical in vitro
Hepatocytes Primary: He mea hana koʻikoʻi no ka holomua ʻana i ka non-Clinical In Vitro Drug ResearchLiver, ma ke ʻano he mea koʻikoʻi no ka hoʻolaha ʻana i ka lāʻau lapaʻau, he hana koʻikoʻi i ka metabolism lāʻau a me nā kaʻina hana ʻawaʻawa. Ua haʻi aku ʻo PriHeluhelu hou aku -
Nā Microsomes: ʻO ka mea i makemake ʻia i loko o ka Vitro Metabolic Model no ka Nonclinical Drug Research
Microsomes: ʻO ka mea i makemake ʻia i loko o ka Vitro Metabolic Model no ka Nonclinical Drug ResearchMicrosomes: wehewehe a me nā hanaMa ka hapanui o nā hihia, pili nā microsomes i nā ʻāpana spherical, vesicular membrane approxHeluhelu hou aku -
Lysosomes (Tritosomes): He ʻōnaehana hoʻāʻo i loko o ka vitro no ka catabolism a i ʻole nā haʻawina paʻa lysosomal.
Nā Huahana IPHASE 'Imumu No.Inoa Huahana Mana'o0151A1.03IPHASE Nā Lysosomes Liver Kanaka, Ke kāne Hui Pū 'ia250μL,2mg/mL0151B1.01IPHASE Monkey(Cynomolgus) Liver Lysosomes, KāneHeluhelu hou aku -
IPHASE Solutions for siRNA Drug In Vitro Metabolism Research
IPHASE Solutions for siRNA Drug In Vitro Metabolism Research Nā lāʻau lapaʻau Nucleic acid, ma muli o ko lākou ʻano ʻenehana kūʻokoʻa, ua lilo i kumu o ka hoʻomohala lāʻau hou i nā makahiki i hala. NuclHeluhelu hou aku -
Hauʻoli i ka hele ʻana i ka DVDMDG Fall Symposium ma Nowemapa 19, 2024!
Ke ʻimi nei i ka noiʻi hou loa ma Cytochrome P450 & SLC Transporters ma IPHASE BiosciencesHeluhelu hou aku -
E hele ana i ka hui ʻAmelika Hui Pū ʻIa no Mass Spectrometry (CASMS).
Ua hauʻoli mākou i ka hele ʻana i ka hui ʻAmelika Hui Pū ʻIa no Mass Spectrometry (CASMS) i ka lā 1 Nowemapa! He lā hoʻoikaika ia e pili ana me nā ʻoihana ʻoihana a loaʻa ka ʻike i nā holomua hou loa i ka spectrometry nuipa.Heluhelu hou aku